VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, is the first to demonstrate the isolation and analysis of >99% pure circulating tumor-derived DNA (ctDNA).

New England Biolabs has released the Monarch® Mag Cell-free DNA (cfDNA) Extraction Kit, a bead-based method designed for scalable and reproducible isolation of low abundance cfDNA from plasma, serum, ...

VolitionRx (VNRX) stock jumped 70% in pre-market after achieving 99% pure tumor DNA isolation and detecting 49/49 cancers in ...

Formalin-fixed paraffin embedding (FFPE) is employed in hospitals around the world to preserve and store clinical samples. However, extracting and purifying DNA from FFPE samples presents challenges, ...

Long-read sequencing is transforming the landscape of genomic research, offering exceptional resolution and accuracy in the analysis of complex genetic structures. From research in genetic analysis to ...